Evoke Pharma (EVOK) Institutional Ownership $4.82 -0.44 (-8.37%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$4.82 0.00 (0.00%) As of 02/21/2025 04:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Evoke Pharma (NASDAQ:EVOK)Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$461.93KNumber ofInstitutional Sellers(last 12 months)0 Get EVOK Insider Trade Alerts Want to know when executives and insiders are buying or selling Evoke Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EVOK Institutional Buying and Selling by Quarter Evoke Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025 Nantahala Capital Management LLC148,194$655K0.0%+163.5%9.946% 11/14/2024 Corsair Capital Management L.P.11,667$56K0.0%N/A1.425% 11/9/2021BlackRock Inc.175,559$228K0.0%+9.2%0.541% 11/2/2021Raymond James Financial Services Advisors Inc.108,545$141K0.0%-8.9%0.335% 8/17/2021 Worth Venture Partners LLC397,742$545K0.2%+18.2%1.229% 8/16/2021 Sabby Management LLC47,431$65K0.0%N/A0.147% 8/13/2021 Geode Capital Management LLC195,760$268K0.0%+22.4%0.605% 8/13/2021 Vanguard Group Inc.1,120,178$1.53M0.0%-1.5%3.460% 8/12/2021 AIGH Capital Management LLC1,701,185$2.33M0.4%+18.7%5.255% 5/20/2021Axiom Investment Management LLC17,500$32K0.0%N/A0.054% 5/19/2021 Worth Venture Partners LLC336,516$616K0.3%N/A1.040% 5/18/2021 Morgan Stanley723,897$1.33M0.0%+43.6%2.236% 5/18/2021 Jane Street Group LLC18,044$33K0.0%N/A0.056% 5/13/2021Axiom Investment Management LLC17,500$32K0.0%N/A0.054% 5/12/2021 UBS Group AG31,757$58K0.0%+1,709.5%0.098% 5/7/2021BlackRock Inc.150,891$276K0.0%+8.2%0.466% 4/9/2021 Pure Financial Advisors Inc.17,647$32K0.0%N/A0.055% 2/24/2021 Virtu Financial LLC18,335$47K0.0%N/A0.069% 2/10/2021 Renaissance Technologies LLC187,276$483K0.0%+739.8%0.710% 2/9/2021 Wells Fargo & Company MN25,117$65K0.0%+17,840.7%0.095% 2/5/2021BlackRock Inc.139,474$360K0.0%+8.7%0.529% (Data available from 1/1/2016 forward) EVOK Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EVOK shares? During the previous two years, the following institutional investors and hedge funds held shares of Evoke Pharma shares: Nantahala Capital Management LLC ($655K), Corsair Capital Management L.P. ($56K).Learn more on EVOK's institutional investors. Which institutional investors have been buying Evoke Pharma stock? The following institutional investors have purchased Evoke Pharma stock in the last 24 months: Nantahala Capital Management LLC ($91.95K), and Corsair Capital Management L.P. ($11.67K). How much institutional buying is happening at Evoke Pharma? Institutional investors have bought a total of 103,612 shares in the last 24 months. This purchase volume represents approximately $461.93K in transactions. Related Companies MRNS Major Shareholders NKGN Major Shareholders PULM Major Shareholders CMMB Major Shareholders LEXX Major Shareholders CYTH Major Shareholders ALLK Major Shareholders CDIO Major Shareholders DARE Major Shareholders XCUR Major Shareholders This page (NASDAQ:EVOK) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evoke Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evoke Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
